Objective:Simple, rapid and reproducible reversed-phase high performance liquid chromatography (RP-HPLC) and ultraviolet derivative spectrophotometric (UVDS) methods for the simultaneous determination of daclatasvir (DAC) and sofosbuvir (SOF) in pure and in pharmaceutical dosage forms have been developed and validated.
Introduction
Hepatitis C is a comprehensive liver disease produced by the hepatitis C virus (HCV) and can increase liver cirrhosis, liver failure, liver cancer and liver transplantation. The standard treatment for HCV is pegylated-interferon (Peg-IFN) and ribavirin (RBV) whoever these agents caused side effects such as bacterial infections, anemia, hematological toxicity, neutropenia and anorectal symptoms [1, 2] . Telaprevir and boceprevir were the first generation direct-acting protease inhibitors that developed and approved for the treatment of genotype I chronic hepatitis C However, they have to be co-administered with interferon and ribavirin therefore they were associated with their common side effects so their effectiveness were limited [3, 4] .
Second-generation direct-acting antiviral drugs were developed and aimed to have a high pangenotypic activity with fewer undesirable side effects. These drugs include daclatasvir and sofosbuvir. Both medicines have effective antiviral activity and genotypic coverage [5, 6] .
Daclatasvir, Methyl [(2S)-1-{(2S)-2-[4-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl) amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-4-yl}-4-biphenylyl)-1Himidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]
carbamate [7] , is a nucleotide analogue NS5A polymerase inhibitor [8] . Only few techniques were reported for the quantitative investigation of DAC including different chromatographic methods [8] [9] [10] [11] [12] , its chiral HPLC separation on a chiral stationary phase [13] , stability indicating HPLC study in bulk and formulations and electrochemical detection with a Chitosan modified electrode [14] .
Sofosbuvir,(S)-Isopropyl2-((S)-(((2R
3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy) (phenoxy) phosphorylamino) propanoate, is a nucleotide analogue HCV NS5B polymerase inhibitor that is used in the treatment of chronic hepatitis C genotypes 1,2,3 or 4 [15] . Sofosbuvir (SOF) was determined by LC-MS/MS methods [8, 16] , the degradation behavior of SOF under various stress conditions was also studied by Swain et al. [18] . Also SOF and its metabolite GS-331007 were determined in rat plasma by ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method [19] [20] [21] [22] and the dissolutionand forced degradation of SOF has also been studied by HPLC [15] .
Although many studies proved separation methods [23] [24] [25] [26] , daclatasvir with sofosbuvir that are co-administrated once per day oral dose achieved a high rate of virological response in patients with HCV genotype 1, 2 or 3. So the aim of this work was to develop and validate [17] two efficient methods using HPLC and UVDS for the simultaneous determination of DAC and SOF in pure form, binary mixtures and in pharmaceutical preparations.
Material and methods

Chemicals and Reagents
Daclatasvir hydrochloride and sofosbuvir were kindly supplied by the national organization for drug control and [27] .
A Shimadzu UV-visible recording spectrophotometer, model UV-2450, with 1 cm quartz cuvettes and connected to an IBM-PC computer loaded with UV Win PC software was used for all the absorbance measurements.
Preparation of Standard and Working Solutions
DAC and SOF stock solutions (1 mg/mL) and working solutions (0.2mg/mL) were prepared in the mobile phase for HPLC method. While DAC and SOF stock solutions (1 mg/mL) and working solution (0.1 mg/mL) were prepared in methanol for UVDS method.
Procedure for the HPLC method
Accurately measured aliquots of stock solutions (1 mg/mL) equivalent to 20-2000 µg of both DAC and SOF were separately transferred into two series of 10-ml volumetric flasks and completed to volume with the mobile phase. 20
µLof each dilution were injected in triplicate. The chromatograms were recorded using chromatographic conditions mentioned above. The recorded areas under peaks (AUP) were plotted versus the corresponding concentrations in µg/mL to obtain the calibration curves of DAC and SOF and the regression equations were calculated.
Procedure for the derivative method
The zero-order absorption spectra of 1 -20 µg/mL for DAC and 2 -50 µg/mL for SOF were scanned within the wavelength range 200 -400 nm against a blank, and then the values of absorbance were measured at the selected wavelengths for both drugs [25] .
As the above procedure, the obtained zero-order absorption spectra of DAC and SOF solutions, respectively, were derivatized to get the second derivative spectra.
Aliquots of DAC or SOF standard working solution equivalent to 8.0 µg/mL for both drugs, were transferred to two volumetric flasks, and the volume was completed with methanol. These two solutions were scanned against a blank 
Application in Pharmaceutical Tablets
An accurate weight of the tablets equivalent to 25 mg of DAC and SOF respectively were dissolved in the mobile phase and filtered on 0.45 µm nylon syringes to produce stock solution of 200 µg/mL DAC and SOF, respectively.
Different aliquots of the tablet working solution equivalent to 200 -600 µg of both DAC and SOF were transferred into a series of volumetric flasks and completed to volume with the mobile phase.The method was performed by applying the standard addition technique.
For the UVDS method, 100 mg of DAC or SOF were transferred to 100-mL volumetric flask, dissolved in methanol to produce a stock tablet solution of 1.00 mg/mL of each drug. A 100 µg/mL working solution was prepared with further dilution of the stock solution with methanol.
Results and Discussion
RP-HPLC Method
Optimization of the Chromatographic Method
To optimize the HPLC assay parameters, the effect of acetonitrile composition and the apparent pH of the mobile To investigate appropriate wavelength for the determination of DAC and SOF, we scanned the solutions of the two drugs individually in the UV-Visible region. Isosbestic point was calculated and found at 265 nm ( Figure 1 ).
Then the quantitation of drug was achieved using UV detector at 265 nm. While the retention time for DAC and SOF were obtained at about 5.5 and 7.3 min, respectively and a flow rate of 1.0 mL min -1 with isocratic elution enable acceptable resolution of drug from possible impurities, in a short elution time at ambient temperature ( Figure   2 ).This HPLC method does not need the addition of internal standard (IS) due to the purity of drug peaks with a clear baseline separation and no tailing.
Examining the separated peaks under the optimum conditions reveals the system suitability and validity of the method. The calculated resolution was 4.56 (> 2), which ensures complete separation. The tailing factor was 1.13 and 1.40 (≤ 2) for DAC and SOF, respectively, which shows the symmetry of the produced peaks within the stated Pharmacopeia's range [22] 
Derivative Spectrophotometric Method
Absorption spectra: zero-order absorption spectra of DAC and SOF in methanol ( Figure 3 ) show strong spectral overlap, which interfere with direct spectrophotometric analysis of the studied drugs. The suggested spectrophotometric method provide simple, convenient and accurate method for simultaneous analysis of DAC and SOF in their bulk and combined dosage forms without derivatization procedure and interference from overlapped peaks.
First to fourth derivative spectra of methanolic solutions of DAC and SOF at appropriate concentrations were taken and observed. The good resolution of the derivative spectra allowed selecting the optimal working wavelengths from several zero -crossing wavelengths, i.e., those which exhibited the best linear response to analyte concentration and higher sensitivity.
The second derivative spectrophotometric method ( 2 D) for determination of DAC as well as SOF in a mixture was the best than the other derivatives since the derivative absorbance peaks of these drugs were more sharper, smoother and well isolated (Figures 3 &4) .The wavelengths at 350 nm for DAC and 288 nm for SOF were considered to be the zero-crossing wavelengths and would be examined to be the optimum working wavelengths for the second derivative 
Accuracy
The previously mentioned procedures under linearity were repeated three times for five different concentrations of pure samples. calculated and tabulated in Table 1 . The results indicate an adequate accuracy. Comparing our methods with other DAC previous works was performed and it was found thatthe best RSD result were achieved for both UVD2 (0.0006 %) and HPLC (0.1%) method, compared to Vikas et al. [28] , jeevana et al. [29] , Hanaa et al. [30] and Ashoket al.
[31] which were 0.121 %, 0.058%, 0.236 % and 0.15% , respectively.
Precision
The intraday precision (repeatability) was evaluated by assaying freshly prepared drug solutions at concentrations of 50, 100 and 200 µg mL -1 (HPLC method) and 5, 10 and 20 or 10, 20 and 40 µg mL -1 ( 2 D method for DAC or SOF, respectively), within the same day and in three successive days (interday precision). The results listed in Table 1, show that no significant difference for the assay, which tested within day (repeatability) and between day (reproducibility). The relative standard deviation (RSD) was less than 1% indicates high degree of precision of the proposed methods.
Selectivity
Method selectivity for each drug in presence of the other was attained by preparing different mixtures of DAC and SOF within linearity range. The results obtained in Table 2 
Specificity
The specificity of the methods was investigated by observing any interference encountered from the common tablet excipients such as talc, glucose, sucrose, starch and magnesium stearate. These excipients did not interfere with the proposed methods. This fact indicates good selectivity of the methods to determine of these drugs in drug formulations.
Detection and Quantification Limits
For HPLC method
The limit of detection (LOD) represents the concentration of analyte that would yield a signal-to-noise ratio of 3:1 and the limit of quantification (LOQ) represents the concentration of analyte that would yield a signal-to-noise ratio of 10:1. The results are tabulated in Table 1 .
For 2 D method
According to ICH recommendation [22] , the approach based on the SD of the response and the slope (b) of Beer's law was used for determining the detection and quantification limits. The values of low limits of detection (LOD) and quantification (LOQ) were assessed practically and listed in Table 1 .
Stability of Standard and Sample Solutions
Stability of standard and sample solutions was evaluated at room temperature for 3 days. The relative standard deviation was found < 2%. It indicates both standard and sample solutions were stable up to 3 days at room temperature.
Recovery studies
The accuracy of the HPLC and UVDS methods was also checked by performing recovery experiments using the standard addition method. Known amount of drug were added to reanalyzed tablet solution, then the spiked samples were analyzed by two methods. The results of the recovery analyses are tabulated in table 3. It was concluded that the proposed methods are sufficiently accurate and precise and can be applied to pharmaceutical dosage forms and high recovery data show that the two methods are free from the interference of the excipients used in the formulations. 
Method
Robustness and ruggedness
Small deliberate variations of the experimental conditions for HPLC method were applied in order to determine the effect on R T and resolution, three different C 18 columns were tested and showed that any stationary phase with strongly deactivated silica could be used. Changes in mobile phase composition (±2%) or the flow rate ±0.2 mL/min, pH of the mobile phase (±0.1) and column temperature was varied ±5 0 C, did not significantly affect the HPLC method, illustrating the robustness of the method.
The ruggedness of the proposed methods was evaluated by applying the developed procedure to assay of drug using the same instrument by two different analysts under the same optimized conditions at different days. Intermediate precision value (RSD) in both instances were ≤ 2% indicate acceptable ruggedness.
Analytical Applications
The developed and validated HPLC and UVDS ( 2 D) methods were successfully applied to bulk powder and commercially available tablets of studied drugs. The DAC and SOF content of tablets were determined using regression equation method. The obtained amount of DAC or SOF and statistical analysis are given in table 4 (HPLC method) and 
Conclusion
This study investigates the first developed and validated RP-HPLC and UVDS methods for the determination of DAC and SOF in a mixture. The method was validated in terms of linearity, precision, accuracy, selectivity, detection limit, quantification limit and robustness and can be used for the determination of DAC and SOF either alone or in combined form. The availability of the instrumentation, simplicity of procedures, speed, precision and accuracy of the suggested techniques make these methods more valuable and attractive for uses.
The present HPLC method can be considered simple, rapid, and easy to apply, making it very suitable for routine analysis of DAC and SOF in pharmaceutical formulations. It involves a single step procedure for the preparation of the samples and direct injection. Sample preparation and analytical procedure run times are short so this method can be successfully applied for routine analysis in quality control. The UVDS method of analysis is simple, rapid, sensitive and accurate analytical method for routine quantitative determination of samples where they reduce unnecessary tedious sample preparations.
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